United States · 
Who invested in ALX Oncology?
ALX Oncology's investors include RA Capital Management, Janus Henderson Investors, Vivo Capital, Redmile Group and Foresite Capital.
United States · Funded startup
Who invested in ALX Oncology
Funding summaryUpdated 26 Oct 2026
$10Mraised across 1 round since 2026, from 1 source
- Latest round
- Debt, $10MJun 2026
- Investors
- 5
The rounds
- Jun 2026Debt$10M
Source recorded
Founders and team
From ALX Oncology's own website: 2 on the team.
- Jason LettmannChief Executive Officer
- Michael ListgartenGeneral Counsel
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 3 firms list ALX Oncology as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about ALX Oncology
How much has ALX Oncology raised?
ALX Oncology has raised $10M across 1 round since 2026.
When did ALX Oncology last raise?
ALX Oncology's most recent round was a Debt of $10M in Jun 2026.
What was ALX Oncology's biggest round?
Its most recent round, $10M in Jun 2026, is also its largest on record.
Who backed ALX Oncology first?
ALX Oncology's first round on record, in Jun 2026, was backed by RA Capital Management, Janus Henderson Investors and Vivo Capital and 2 others.
What stage is ALX Oncology at?
ALX Oncology's latest named round is a Debt, in Jun 2026.
Where is ALX Oncology based?
ALX Oncology is based in the United States.
Companies like ALX Oncology
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.